Literature DB >> 20203448

[Successful treatment of a gastrointestinal stromal tumor with liver metastases in a case that tolerated imatinib administration, by radiofrequency ablation using contrast-enhanced ultrasonography].

Tatsuya Minami1, Shinpei Sato, Yoshitaka Watanabe, Rie Matsuda, Satoru Yotsuya, Akishige Yamada, Teruyuki Tanaka, Shintaro Kondo, Tetsuo Ebihara, Gouichi Togo, Kazuto Yamazaki, Yasuo Ishida.   

Abstract

We report a case of gastrointestinal stromal tumor (GIST) with liver metastases which was undetectable by B-mode ultrasonography, effectively treated by radiofrequency ablation using contrast-enhanced ultrasonography US. A 43-year-old woman was admitted for the treatment of 6 lesions up to 4cm in diameter, which had emerged from necrotic sites within the liver after imatinib treatment. The recurrent lesions were not detected on B-mode US, and it was difficult to perform radiofrequency ablation (RFA) treatment. Using a contrast-enhanced agent (sonazoid), the recurrent lesions were detected and treated by RFA. RFA is considered to be an effective treatment for GIST with liver metastases that tolerate imatinib administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203448

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  1 in total

1.  Successful treatment of gastrointestinal stromal tumor with multiple liver metastases with radiofrequency ablation and imatinib: A case report.

Authors:  Chunchuan Fu; Nianzhou Liu; Qingsong Deng; Yunhua Tan; Kuansheng Ma; Ping Bie
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.